Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antisense oligonucleotides in neurological disorders
Claudia D. Wurster, Albert C. Ludolph
Therapeutic Advances in Neurological Disorders (2018) Vol. 11, pp. 175628641877693-175628641877693
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Long noncoding RNAs in cancer metastasis
Siyuan Liu, Ha X. Dang, Daniel A. Lim, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 446-460
Open Access | Times Cited: 504
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Jonathan Mill, Merit Cudkowicz, Pamela J. Shaw, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 2, pp. 109-119
Open Access | Times Cited: 453
Alternative splicing and cancer: a systematic review
Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 309
A walk through tau therapeutic strategies
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
Hyun Su Min, Hyun Jin Kim, Mitsuru Naito, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 21, pp. 8173-8180
Open Access | Times Cited: 164
Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics
Thiruganesh Ramasamy, Hima Bindu Ruttala, Shankar Munusamy, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 861-878
Closed Access | Times Cited: 72
Gene therapy for CNS disorders: modalities, delivery and translational challenges
Jingjing Gao, Swetharajan Gunasekar, Ziting Xia, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 8, pp. 553-572
Closed Access | Times Cited: 23
Clinical Trials in Alzheimer’s Disease: A Hurdle in the Path of Remedy
Alexandra E. Oxford, Erica S. Stewart, Troy T. Rohn
International Journal of Alzheimer s Disease (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 99
STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies
Debra Abramov, Noah Guy Lewis Guiberson, Jacqueline Burré
Journal of Neurochemistry (2020) Vol. 157, Iss. 2, pp. 165-178
Open Access | Times Cited: 83
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Sofia Toniolo, Arjune Sen, Masud Husain
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9318-9318
Open Access | Times Cited: 72
Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing
Apoorva Sarode, Yuchen Fan, Amy E. Byrnes, et al.
Nanoscale Advances (2022) Vol. 4, Iss. 9, pp. 2107-2123
Open Access | Times Cited: 47
Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology
Man Amanat, Christina L. Nemeth, Amena Smith Fine, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2389-2389
Open Access | Times Cited: 47
Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy
Barney Viengkhou, Christine Hong, Curt Mazur, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 4
Open Access | Times Cited: 11
Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model
Lei Sheng, Frank Rigo, C. Frank Bennett, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 6, pp. 2853-2865
Open Access | Times Cited: 67
Insights into lncRNAs in Alzheimer’s disease mechanisms
Dingfeng Li, Juan Zhang, Xiaohui Li, et al.
RNA Biology (2020) Vol. 18, Iss. 7, pp. 1037-1047
Open Access | Times Cited: 58
Cerebrospinal fluid proteomic profiling in nusinersen‐treated patients with spinal muscular atrophy
Tobias Keßler, Pauline Latzer, Dominic Schmid, et al.
Journal of Neurochemistry (2020) Vol. 153, Iss. 5, pp. 650-661
Open Access | Times Cited: 51
Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen
Didu Kariyawasam, Arlene D’Silva, James Howells, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 92, Iss. 1, pp. 78-85
Open Access | Times Cited: 51
Persistent repression of tau in the brain using engineered zinc finger protein transcription factors
Susanne Wegmann, Sarah L. DeVos, Bryan Zeitler, et al.
Science Advances (2021) Vol. 7, Iss. 12
Open Access | Times Cited: 49
Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease
Ettaib El Marabti, Omar Abdel‐Wahab
Trends in Molecular Medicine (2021) Vol. 27, Iss. 7, pp. 643-659
Open Access | Times Cited: 47
Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives
Gayathri R. Ediriweera, Liyu Chen, Justin J. Yerbury, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 6, pp. 2142-2160
Closed Access | Times Cited: 46
Small molecule targeting of biologically relevant RNA tertiary and quaternary structures
Martina Zafferani, Amanda E. Hargrove
Cell chemical biology (2021) Vol. 28, Iss. 5, pp. 594-609
Open Access | Times Cited: 43
Genetic therapeutic advancements for Dravet Syndrome
Ellie Chilcott, Juan Antinao Díaz, Cori Bertram, et al.
Epilepsy & Behavior (2022) Vol. 132, pp. 108741-108741
Open Access | Times Cited: 36
Prevalence of Neuropsychiatric Disorders in Duchenne and Becker Muscular Dystrophies: A Systematic Review and Meta-analysis
Carlos Pascual‐Morena, Iván Cavero‐Redondo, Sara Reina‐Gutiérrez, et al.
Archives of Physical Medicine and Rehabilitation (2022) Vol. 103, Iss. 12, pp. 2444-2453
Closed Access | Times Cited: 32
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges
Jong Won Lee, Man Kyu Shim, Hyo‐Suk Kim, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115073-115073
Open Access | Times Cited: 23
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
Megi Meneri, Elena Abati, Delia Gagliardi, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1254-1254
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top